Blog
2 Cannabis Growth Stocks That Could Double By 2024
When you're looking for engines of growth to fuel your portfolio, marijuana stocks just might be up your alley. With the cannabis industry still in its infancy in the U.S., there are plenty of
Is Just Eat Takeaway Choking on Grubhub?
Shares of multinational food delivery business Just Eat Takeaway (NASDAQ: GRUB) have continued to slide in the days since the company delivered a lackluster forecast in its Oct. 21 investor
eBay Dropped After Earnings: Should You Consider It?
eBay (NASDAQ: EBAY) stock slid immediately following the release of its third-quarter earnings results on Oct. 27, despite posting strong revenue and earnings numbers. Weak revenue guidance came
Is Now a Good Time to Buy PayPal Stock?
PayPal (NASDAQ: PYPL) recently confirmed that it would not be acquiring Pinterest (NYSE: PINS) after headlines were buzzing that the fintech giant might acquire the social media stock. While
How to Retire With $1 Million on an Average Salary
Saving for retirement isn't easy, especially as costs continue to rise. While Social Security benefits can help to an extent, your monthly checks were never designed to be a primary source of
Got $5,000? 3 Tech Stocks to Buy and Hold For the Long Term
$5,000 might not seem like much in the tech sector, where stocks often cost hundreds or thousands of dollars per share. However, the best tech stocks can still transform a modest investment into a
Bristol Myers Squibb Just Got Some Great Regulatory News
It's no secret that Bristol Myers Squibb (NYSE: BMY) will need to innovate to grow as its three top drugs -- Revlimid, Eliquis, and Opdivo -- face patent expirations during the next decade
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
Vertex Pharmaceuticals (NASDAQ: VRTX) outperformed the broader market in the past decade. The drugmaker owes this performance to its monopoly in the market for medicines that treat the underlying
Starbucks to Nearly Double New Store Growth in Fiscal 2022
Starbucks (NASDAQ: SBUX) reported fiscal 2021 fourth-quarter earnings after the market closed on Oct. 28. As part of the announcement, management unveiled fiscal 2022 projections.
One expectation
Like Free Money? Here's 1 Retirement Move Worth Making
How many opportunities in life do you get to score free money? If you're like most people, not many. Sure, you might get some cash back from your credit cards for making purchases, but for the
Roku and Alphabet Are at Loggerheads: Here's What Investors Need to Know
Will Roku's (NASDAQ: ROKU) battle with Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG) ever come to a resolution? In this segment of Backstage Pass, recorded on Oct. 22, Fool.com contributors Jason Hall
2 Top Stocks That Could Turn $500 Into $5,000 in 10 Years
Major secular trends are a great starting point when looking for new investment ideas. Innovations like cloud computing and digital financial services have already changed the world, and those
Don't Let McCormick's Bland Stock Performance Keep You From Seeing Its Spicy Potential
Take a walk down any grocery store's spice aisle and you're sure to notice the prominent placement and vast array of products from McCormick (NYSE: MKC). The company is a global leader in flavor and
Could This Be the First Big Step Towards Marijuana Legalization?
A big obstacle in marijuana legalization is that some lawmakers remain skeptical about the health benefits of cannabis. While there is plenty of anecdotal evidence out there, cold hard facts are
WeWork Finally Went Public: Key Takeways for Investors
When WeWork (NYSE: WE) finally became a publicly traded company on Oct. 21 through a SPAC merger, the long and dramatic saga leading up to its IPO finally came to an end. In this segment of
Did Dune Just Save AMC Entertainment?
Studios undoubtedly realize their simultaneous movie release schedule is backfiring. Big-budget films are generating large returns at the box office, but the studios are undercutting the receipts
3 High-Yield Tech Stocks to Buy in November
It's hard to find investment income right now. Savings accounts pay just 0.06% on average, while the S&P 500's current dividend yield is just 1.33%. Inflation is chewing up your money, averaging
Investing in the Future of Remote Work: 3 Stocks That Are Better Than WeWork
WeWork (NYSE: WE) led global headlines when it achieved it's long-awaited public debut via SPAC on Oct. 21. But if you're interested in investing in the future of work, there may be better uses of
1 Stock Slumped Despite Strong Earnings. Should You Buy the Dip?
Twilio (NYSE: TWLO) dropped nearly 18% after it reported relatively strong earnings after the market's close on Oct. 27. The business saw strong growth in revenue, but other factors led to the drop
Could Shiba Inu Fall 90% (or More)? Here's What History Suggests
Looking back to the beginning of the 20th century, no asset class has been more consistent at building wealth for investors than the stock market. Although stocks do have their down years, the
3 Companies That Went Public Last Month
If you're searching for new stocks to add to your portfolio, initial public offerings (IPOs) can be a tempting option.
An IPO occurs when a company begins offering shares of stock to the public, and
MercadoLibre Has a Secret Weapon in Mercado Pago
You might not think of MercadoLibre (NASDAQ: MELI) as a fintech stock. The internet retailer dominates e-commerce in South America. But its payments solution, Mercado Pago, might be the secret
Are We Underestimating the Supply Chain Crisis as a Threat to the Global Economy?
The supply chain crisis is impacting people all over the world, and it doesn't look anywhere close to ending. In this segment of Backstage Pass, recorded on Oct. 22, Fool.com contributors Jason
Here's How Much Extra Money Pfizer Will Make From Vaccines for Younger Kids This Year
Moderna is holding off on filing for Emergency Use Authorization (EUA) for its COVID-19 vaccine in children ages six to 11. The company made this decision after the U.S. Food and Drug Administration
Why Ocugen Stock Will Probably Soar Tomorrow -- but Shouldn't
Moderna's shares have more than tripled in value so far this year. BioNTech has been an even bigger winner for investors. Buying and holding the stocks of leading COVID-19 vaccine makers has turned


